New Delhi, India

Mohammad Khalid Zakaria

This inventor holds 1 USPTO granted patent. Top assignees: All India Institute of Medical Sciences, National Brain Research Centre. Active years: 2018.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Mohammad Khalid Zakaria

Introduction

Mohammad Khalid Zakaria is an accomplished inventor based in New Delhi, India. He has made significant contributions to the field of therapeutic modalities through his innovative research and patents. His work focuses on cell-specific targeting, which has the potential to revolutionize treatment methods.

Latest Patents

One of his notable patents is titled "Placental like alkaline phosphatase (PLAP) promoter mediated cell targeting." This invention relates to a cell-specific therapeutic modality that utilizes a region of the PLAP Promoter. The invention emphasizes the specific expression of therapeutically useful PLAP sequences for targeted transcriptional activation of this gene. Additionally, it discusses the PLAP region's potential use in combination with other regions, such as enhancer sequences, to enhance cell or tumor-specific gene expression. This patent showcases his innovative approach to addressing complex medical challenges.

Career Highlights

Throughout his career, Zakaria has worked with prestigious institutions, including the National Brain Research Centre and the All India Institute of Medical Sciences. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Subrata Sinha and Imran Khan. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.

Conclusion

Mohammad Khalid Zakaria's contributions to the field of cell-specific therapeutic modalities highlight his innovative spirit and dedication to advancing medical science. His patent on PLAP promoter-mediated cell targeting is a testament to his expertise and commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…